Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Application History
8 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 11, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
Apr 9, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Sep 21, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 21, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 21, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 25, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 27, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicines for the modification of genes and treatment of diseases; cell and gene therapy products including products with protein expression
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Providing information in the fields of genetic medicine and drug delivery
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and biotechnology research and analysis in the fields of cell and gene therapy, and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
041
042